#revenueforecast — Public Fediverse posts

https://www.europesays.com/unitedstates/25534/ No longer lagging, Oregon economic growth catching up with nation, state economists report • Oregon Capital Chronicle #CarlRiccadonna #EconomicGrowth #Economy #GOPMegalaw #MichaelKennedy #Oregon'sEconomy #RegionalEconomy #RevenueForecast #tariffs #TrumpTariffs

https://www.europesays.com/people/212169/ Arm Holdings Surges on AI Data Center Demand Despite Supply Challenges, ETTelecom #AdjustedEPS #AIDataCenter #ArmHoldings #ChipTechnology #RenéHaas #RevenueForecast #SmartphoneMarket

No longer lagging, Oregon economic growth catching up with nation, economists report

https://fed.brid.gy/r/https://lincolnchronicle.org/no-longer-lagging-oregon-economic-growth-catching-up-with-nation-economists-report/

https://www.europesays.com/britain/96805/ A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030 #AnalystSkepticism #AstraZeneca #BigPharma #BMS #BristolMyersSquibb #Calquence #Datroway #DealCapacity #ELILILLY #Enhertu #FinancialEngineering #Imfinzi #MonteCarloModel #OncologyPortfolio #Opdivo #Opdualag #PharmaMerger #PharmaceuticalIndustry #R&DSpending #RevenueForecast #Tagrisso #Yervoy

So let me get this straight: #SpaceX, with its imaginary $4.3T revenue forecast, is planning a record-breaking #IPO where you can buy almost nothing? 🤑🤔 Who knew buying shares was like playing "Where's Waldo?" but with $75 billion on the line. 🚀💸
https://www.matteast.io/spacex-escape-velocity.html #SpaceInvesting #RevenueForecast #WhereIsWaldo #StockMarket #HackerNews #ngated

QUALCOMM'S FUTURE UNCERTAIN AS REVENUE FORECAST MISSES TARGETS

Qualcomm's Q3 revenue forecast misses targets due to chip shortages, impacting Chinese handset market. CEO sees future recovery.

#Qualcomm, #ChipShortage, #TechNews, #RevenueForecast, #ChineseMarket

https://newsletter.tf/qualcomm-revenue-forecast-misses-targets-chip-shortage/

Qualcomm's Q3 revenue forecast missed expectations, showing a significant impact from the global chip shortage. This is a big change from previous predictions.

#Qualcomm, #ChipShortage, #TechNews, #RevenueForecast, #ChineseMarket
https://newsletter.tf/qualcomm-revenue-forecast-misses-targets-chip-shortage/

Microchip Technology plans to close its Tempe, AZ plant in Q3 2025, affecting 500 employees, and lowers its Q3 revenue forecast. ⚠️ #MicrochipTechnology #Tempe #Manufacturing #TechNews #Q3Forecast #BusinessNews #EmploymentImpact #RevenueForecast

UBS Executive Highlights AI’s Impact on Banking - UBS is witnessing a transformative shift in client interactions driven by artifici... - https://news.bitcoin.com/ubs-executive-highlights-ais-impact-on-banking/ #artificialintelligence #sabinekeller-busse #financialsector #revenueforecast #aiindustry #finance #banking #ubs #ai

Cisco previously revised its revenue and profit forecasts for the full year, attributing the decline to slowing demand for networking equipment. Consequently, the company is expected to streamline its operating expenses through layoffs, a strategy employed by other tech giants like Alphabet, Amazon, and UPS. #CiscoSystems #BusinessRestructuring #Layoffs #RevenueForecast #OperatingExpenses #TechIndustry

As Cisco Systems restructures its business to target areas with higher growth potential, reports suggest that the company is preparing to lay off thousands of employees. An official announcement regarding the layoffs is anticipated following the release of the company's balance sheet on Wednesday. #CiscoSystems #BusinessRestructuring #Layoffs #RevenueForecast #OperatingExpenses #TechIndustry

Strong demand for Botox, generating $1.49 billion in quarterly revenue, persists despite intense competition. AbbVie's 2024 earnings per share forecast falls in the range of $11.05 - $11.25 billion, aligning with analyst estimates at the upper end of this range, specifically at $11.24. #AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations

The negative outlook stemming from CVS Health's decision to delist Humira poses a challenge, but AbbVie aims to counter the lost revenue with new immunology products Skyrizi and Rinvoq. In its 2027 projection, AbbVie raised the revenue forecast for these drugs from $21 billion to $27 billion.#AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations